지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis
Journal of Gynecologic Oncology
2024 .01
Olaparib, a selective PARP-1 inhibitor, aggravates radiation induced intestinal injury
한국실험동물학회 학술발표대회 논문집
2022 .07
난소암 표적치료 및 면역치료
대한의사협회지
2016 .01
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
Journal of Gynecologic Oncology
2024 .09
BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis
Journal of Breast Cancer
2021 .10
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study
Journal of Gynecologic Oncology
2024 .09
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
Journal of Gynecologic Oncology
2022 .07
Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
Cancer Research and Treatment
2023 .01
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer
Journal of Gynecologic Oncology
2024 .07
Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
Journal of Breast Cancer
2015 .01
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer
Journal of Gynecologic Oncology
2022 .11
Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-analysis from Randomized Clinical Trials and Propensity Score Matching of Multicentre Cohort Study
Cancer Research and Treatment
2022 .10
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin
Cancer Research and Treatment
2019 .01
Major clinical research advances in gynecologic cancer in 2014
Journal of Gynecologic Oncology
2015 .01
Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
Journal of Gynecologic Oncology
2016 .01
Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study
Cancer Research and Treatment
2019 .01
Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Cancer Research and Treatment
2020 .01
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study
Journal of Gynecologic Oncology
2024 .09
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer
Journal of Gynecologic Oncology
2024 .07
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis
Cancer Research and Treatment
2017 .07
0